# China NMPA Inspection - Gansu Boxiang Pharmaceutical Co., Ltd. - January 25, 2019

Source: https://www.globalkeysolutions.net/records/china_inspection/gansu-boxiang-pharmaceutical-co-ltd/ca3ad57c-e11a-400f-8d44-4254bee3d33e/
Source feed: China

> China NMPA unannounced inspection for Gansu Boxiang Pharmaceutical Co., Ltd. published January 25, 2019. Gansu Boxiang Pharmaceutical Co., Ltd. underwent an unannounced inspection by the National Medical Products Administration Audit and Inspection Center

---

## Details

- Record Type: CHINA_INSPECTION
- Title: Notification of Unannounced Inspection of Gansu Boxiang Pharmaceutical Co., Ltd.
- Company Name: Gansu Boxiang Pharmaceutical Co., Ltd.
- Publication Date: 2019-01-25
- Product Type: Drugs
- Summary: Gansu Boxiang Pharmaceutical Co., Ltd. underwent an unannounced inspection by the National Medical Products Administration Audit and Inspection Center from October 17-19, 2018, as part of the national annual inspection plan for pharmaceutical business enterprises. The inspection identified several critical non-compliance issues. Firstly, the company failed to adequately verify the legal qualifications of its suppliers and the legality of purchased drugs, along with the credentials of supplier sales personnel. A significant financial irregularity was noted, where the company did not issue invoices for Chinese herbal medicine slices sold to a clinic in Zhangchuan County since 2017. Furthermore, the company neglected to conduct an internal audit of its quality management system in 2017, a fundamental requirement for maintaining quality standards. Operational deficiencies included the quality management department's failure to verify computer system operation permissions. Lastly, potential conflicts of interest were identified as the quality manager concurrently performed purchasing duties, and receiving personnel also handled receiving responsibilities, violating separation of duties principles. These actions were deemed serious violations of the "Good Supply Practice for Pharmaceutical Products" regulations. Consequently, the Gansu Provincial Drug Administration revoked Gansu Boxiang Pharmaceutical Co., Ltd.'s Good Supply Practice (GSP) certification and initiated an investigation into the company's suspected illegal and irregular business practices.

Company: https://www.globalkeysolutions.net/companies/gansu-boxiang-pharmaceutical-co-ltd/872e7246-06ac-4bb5-a9f6-fbe682b0a2c4/